The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Filippo Pietrantonio, Filippo de Braud et al.|British Journal of Cancer|2020

Cited by 350